182 related articles for article (PubMed ID: 31839729)
1. Unexpected abnormal coagulation test results in a 2-year-old child: A case report.
Banković Radovanović P; Živković Mikulčić T; Simović Medica J
Biochem Med (Zagreb); 2020 Feb; 30(1):011002. PubMed ID: 31839729
[TBL] [Abstract][Full Text] [Related]
2. Underestimation of plasma level of factor V coagulant activity and fibrinogen concentration together with prolonged prothrombin time, activated partial thromboplastin time and thrombin time can result from pre-analytical very low calcium level in citrated sample tube.
d'Audigier C; Delassasseigne C; Robert A; Eschwège V
Int J Lab Hematol; 2016 Feb; 38(1):50-3. PubMed ID: 26406495
[TBL] [Abstract][Full Text] [Related]
3. Heparin and citrate additive carryover during blood collection.
Keppel MH; Auer S; Lippi G; von Meyer A; Cornes M; Felder TK; Oberkofler H; Mrazek C; Haschke-Becher E; Cadamuro J
Clin Chem Lab Med; 2019 Nov; 57(12):1888-1896. PubMed ID: 31377734
[TBL] [Abstract][Full Text] [Related]
4. Pre-analytical practices for routine coagulation tests in European laboratories. A collaborative study from the European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM).
Kristoffersen AH; Stavelin AV; Ajzner E; Kristensen GBB; Sandberg S; Van Blerk M; Kitchen S; Kesseler D; Woods TAL; Meijer P
Clin Chem Lab Med; 2019 Sep; 57(10):1511-1521. PubMed ID: 31085743
[TBL] [Abstract][Full Text] [Related]
5. Reduction of preanalytical errors due to in vitro activation of coagulation.
Bartels PC; Schoorl M; van Bodegraven AA
Clin Lab; 2001; 47(9-10):449-52. PubMed ID: 11596906
[TBL] [Abstract][Full Text] [Related]
6. Quality standards for sample collection in coagulation testing.
Lippi G; Salvagno GL; Montagnana M; Lima-Oliveira G; Guidi GC; Favaloro EJ
Semin Thromb Hemost; 2012 Sep; 38(6):565-75. PubMed ID: 22669757
[TBL] [Abstract][Full Text] [Related]
7. Croatian Society of Medical Biochemistry and Laboratory Medicine: National recommendations for blood collection, processing, performance and reporting of results for coagulation screening assays prothrombin time, activated partial thromboplastin time, thrombin time, fibrinogen and D-dimer.
Bronić A; Coen Herak D; Margetić S; Milić M
Biochem Med (Zagreb); 2019 Jun; 29(2):020503. PubMed ID: 31223257
[TBL] [Abstract][Full Text] [Related]
8. [Analysis of an abnormal coagulation profile in children qualified for adenoidectomy/tonsilectomy].
Kitszel A; Poznańska M; Krawczuk-Rybak M
Otolaryngol Pol; 2007; 61(2):158-61. PubMed ID: 17668802
[TBL] [Abstract][Full Text] [Related]
9. Clinically significant heparin carryover on the ACL 300R.
Karsan A; MacLaren I; Pi D; Wadsworth L
Am J Clin Pathol; 1992 Aug; 98(2):240-2. PubMed ID: 1510037
[TBL] [Abstract][Full Text] [Related]
10. The need for routine pre-operative coagulation screening tests (prothrombin time PT/partial thromboplastin time PTT) for healthy children undergoing elective tonsillectomy and/or adenoidectomy.
Asaf T; Reuveni H; Yermiahu T; Leiberman A; Gurman G; Porat A; Schlaeffer P; Shifra S; Kapelushnik J
Int J Pediatr Otorhinolaryngol; 2001 Dec; 61(3):217-22. PubMed ID: 11700191
[TBL] [Abstract][Full Text] [Related]
11. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
Raffini LJ; Niebanck AE; Hrusovsky J; Stevens A; Blackwood-Chirchir A; Ohene-Frempong K; Kwiatkowski JL
Pediatr Blood Cancer; 2006 Oct; 47(5):589-93. PubMed ID: 16123995
[TBL] [Abstract][Full Text] [Related]
12. Review of coagulation preanalytical variables with update on the effect of direct oral anticoagulants.
Gosselin RC
Int J Lab Hematol; 2021 Jul; 43 Suppl 1():109-116. PubMed ID: 34288452
[TBL] [Abstract][Full Text] [Related]
13. Are tube fill volumes below 90% a rejection criterion for all coagulation tests?
Sena Odabasi M; Yalcinkaya Kara ZM
Lab Med; 2024 Jul; 55(4):442-446. PubMed ID: 38104249
[TBL] [Abstract][Full Text] [Related]
14. Effect of freezing plasma at -20°C for 2 weeks on prothrombin time, activated partial thromboplastin time, dilute Russell viper venom time, activated protein C resistance, and D-dimer levels.
Foshat M; Bates S; Russo W; Huerta A; Albright K; Giddings K; Indrikovs A; Qian YW
Clin Appl Thromb Hemost; 2015 Jan; 21(1):41-7. PubMed ID: 24842886
[TBL] [Abstract][Full Text] [Related]
15. Should healthy children who will undergo minor surgery be screened for coagulation disorder?
Kang S; Yoon HS; Lee EH
Pediatr Hematol Oncol; 2016 May; 33(4):233-8. PubMed ID: 27166650
[TBL] [Abstract][Full Text] [Related]
16. Sodium citrate blood contamination by K2 -ethylenediaminetetraacetic acid (EDTA): impact on routine coagulation testing.
Lima-Oliveira G; Salvagno GL; Danese E; Favaloro EJ; Guidi GC; Lippi G
Int J Lab Hematol; 2015 Jun; 37(3):403-9. PubMed ID: 25308126
[TBL] [Abstract][Full Text] [Related]
17. Bruises, blood coagulation tests and the battered child syndrome.
Lee AC
Singapore Med J; 2008 Jun; 49(6):445-9; quiz 450. PubMed ID: 18581014
[TBL] [Abstract][Full Text] [Related]
18. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
Angelos MG; Hamilton GC
Emerg Med Clin North Am; 1986 Feb; 4(1):95-113. PubMed ID: 3512249
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the main coagulation tests in the presence of hemolysis in healthy subjects and patients on oral anticoagulant therapy.
D'Angelo G; Villa C; Tamborini A; Villa S
Int J Lab Hematol; 2015 Dec; 37(6):819-33. PubMed ID: 26305688
[TBL] [Abstract][Full Text] [Related]
20. Laboratory diagnosis of bleeding disorders. Basic screening tests.
Palmer RL
Postgrad Med; 1984 Dec; 76(8):137-42, 147-8. PubMed ID: 6334288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
